U.S. FDA Approves Mirati’s Lung Cancer Drug
“The U.S. Food and Drug Administration approved Mirati Therapeutics Inc’s lung cancer drug adagrasib, the company said on Monday, sending its shares up more than 8% in extended trading.”

New treatment for early-stage lung cancer has Jami Way living the normal life she wants
“‘There are so many different therapies and great doctors who want to keep you alive and get you more years,’ says the Thousand Oaks resident. Jami Way recites a mantra out loud before swallowing a pill each morning intended to prevent a return of lung cancer.”

What if there was a map to finding the best treatment for lung cancer?
“(BPT) – You’re an avid runner and cyclist. You eat well and don’t smoke. Overall, you’re doing all the right things when it comes to your health. Then you get diagnosed with advanced lung cancer. You know you’re not invincible, but lung cancer didn’t even seem like a possibility.”

Lung Cancer Intraocular Metastases in the Era of Targeted Therapy
“The following is a summary of “Outcomes of Intraocular Metastasis From Lung Cancer in the Era of Targeted Therapy: A Systematic Review and Pooled Analysis” published in the December 2022 issue of Clinical Lung Cancer by Maller et al.”

FDA Approves Second KRAS Drug for Lung Cancer
“Krazati led to tumor shrinkage in 43% of previously treated NSCLC patients with KRAS G12C mutations.”

American Lung Association to Study New Treatment Approach for Lung Cancer
“Newswise — Sean P. Pitroda, MD, Assistant Professor of Radiation and Cellular Oncology at the University of Chicago, has received a Lung Cancer Discovery Award and been selected to join the American Lung Association Research Team for his work to improve treatment response in patients with metastatic non-small-cell lung cancer (mNSCLC).”

FDA Approves “Glowing Tumor” Imaging Drug to Aid Lung Cancer Surgery
“PHILADELPHIA—The U.S. Food and Drug Administration (FDA) has approved the targeted imaging agent Cytalux (pafolacianine) for use in lung cancer surgery. This injectable diagnostic binds to cancerous tissue and glows when stimulated by near-infrared light, making it easier for surgeons to remove tumors completely while sparing healthy tissue.”

Living life to the fullest despite Stage 4 lung cancer
“A young woman is shocked to receive an advanced lung cancer diagnosis. Her luck changed when her care team found a targetable genetic mutation. She will be riding on City of Hope’s Rose Parade float in 2023.”

Lung Cancer Summit Highlights the Importance of Early Screening
“WRNMMC, Bethesda, MD  –  Screening saves lives was the common theme discussed by the various speakers during the annual lung cancer summit hosted by the John P. Murtha Cancer Center (MCC) at Walter Reed National Military Medical Center (WRNMMC), Dec. 6.”

AstraZeneca’s Imfinzi fails in lung cancer trial as a monotherapy to improve OS
“AstraZeneca can add another trial to the list of Imfinzi flops. On Monday, the biopharma announced that its PEARL Phase III trial testing out its blockbuster drug Imfinzi as a monotherapy for lung cancer did not hit its primary endpoint of overall survival.”


Mother, daughter share story to promote lung cancer awareness
“A mother-daughter bond can be a powerful thing. One mother-daughter pair have a story they hope can give precious time to other families.”

Overcoming Barriers to Molecular Testing in Non–Small Cell Lung Cancer
“A comprehensive discussion on how to overcome barriers that may inhibit access to adequate molecular testing in patients with non–small cell lung cancer.”